标题
Neuroprotection in Parkinson’s disease: facts and hopes
作者
关键词
-
出版物
JOURNAL OF NEURAL TRANSMISSION
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-12-11
DOI
10.1007/s00702-019-02115-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Randomized Delayed-Start Trial of Levodopa in Parkinson’s Disease
- (2019) Constant V.M. Verschuur et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systemic peptide mediated delivery of an siRNA targeting α-syn in the CNS ameliorates the neurodegenerative process in a transgenic model of Lewy body disease
- (2019) Brian Spencer et al. NEUROBIOLOGY OF DISEASE
- Selegiline: a molecule with innovative potential
- (2019) Tamás Tábi et al. JOURNAL OF NEURAL TRANSMISSION
- Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti–α-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease
- (2018) Joseph Jankovic et al. JAMA Neurology
- Combined active humoral and cellular immunization approaches for the treatment of Synucleinopathies.
- (2017) Edward Rockenstein et al. JOURNAL OF NEUROSCIENCE
- Genetic Forms of Parkinson's Disease
- (2017) Christine Kim et al. SEMINARS IN NEUROLOGY
- The MPTP Story
- (2017) J. William Langston Journal of Parkinsons Disease
- Effects of Caffeine in Parkinson's Disease: From Neuroprotection to the Management of Motor and Non-Motor Symptoms
- (2017) Rui D.S. Prediger JOURNAL OF ALZHEIMERS DISEASE
- Comparison of Selegiline and Rasagiline Therapies in Parkinson Disease
- (2016) Chava Peretz et al. CLINICAL NEUROPHARMACOLOGY
- Excitotoxic Mechanisms in Non-Motor Dysfunctions and Levodopa- Induced Dyskinesia in Parkinson's Disease: The Role of the Interaction Between the Dopaminergic and the Kynurenine System
- (2016) Zsófia Majláth et al. CURRENT MEDICINAL CHEMISTRY
- Memantine and Kynurenic Acid: Current Neuropharmacological Aspects
- (2016) Zsófia Majláth et al. Current Neuropharmacology
- Iron chelation in the treatment of neurodegenerative diseases
- (2016) Petr Dusek et al. JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY
- α-Synuclein and Lewy pathology in Parkinsonʼs disease
- (2015) Lorraine V. Kalia et al. CURRENT OPINION IN NEUROLOGY
- Prospects of Neurotrophic Factors for Parkinson's Disease: Comparison of Protein and Gene Therapy
- (2015) Andrii Domanskyi et al. HUMAN GENE THERAPY
- Changing the Face of Kynurenines and Neurotoxicity: Therapeutic Considerations
- (2015) Zsuzsanna Bohár et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Parkinson's disease
- (2015) Lorraine V Kalia et al. LANCET
- Disease-modifying strategies for Parkinson's disease
- (2015) Lorraine V. Kalia et al. MOVEMENT DISORDERS
- Emerging therapies for Parkinson's disease: From bench to bedside
- (2014) F.I. Tarazi et al. PHARMACOLOGY & THERAPEUTICS
- Inosine to Increase Serum and Cerebrospinal Fluid Urate in Parkinson Disease
- (2014) Michael A. Schwarzschild et al. JAMA Neurology
- A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease
- (2014) et al. JAMA Neurology
- Phase II safety, tolerability, and dose selection study of isradipine as a potential disease-modifying intervention in early Parkinson's disease (STEADY-PD)
- (2013) MOVEMENT DISORDERS
- Safety/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patients
- (2013) R. T. Bartus et al. NEUROLOGY
- The prion hypothesis in Parkinson's disease: Braak to the future
- (2013) Naomi P Visanji et al. Acta Neuropathologica Communications
- Safety, tolerability and pharmacokinetics after single and multiple doses of preladenant (SCH420814) administered in healthy subjects
- (2012) D. L. Cutler et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Some molecular mechanisms of dopaminergic and glutamatergic dysfunctioning in Parkinson’s disease
- (2012) Dénes Zádori et al. JOURNAL OF NEURAL TRANSMISSION
- Mitochondrial disturbances, excitotoxicity, neuroinflammation and kynurenines: Novel therapeutic strategies for neurodegenerative disorders
- (2012) Dénes Zádori et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Pathogenesis of Parkinson's disease
- (2012) Etienne C. Hirsch et al. MOVEMENT DISORDERS
- Kynurenines in the CNS: recent advances and new questions
- (2012) László Vécsei et al. NATURE REVIEWS DRUG DISCOVERY
- Kynurenines in Parkinson’s disease: therapeutic perspectives
- (2011) Dénes Zádori et al. JOURNAL OF NEURAL TRANSMISSION
- The Promise of Neuroprotective Agents in Parkinson?s Disease
- (2011) Stacey E. Seidl et al. Frontiers in Neurology
- Clinical progression in Parkinson disease and the neurobiology of axons
- (2010) Hsiao-Chun Cheng et al. ANNALS OF NEUROLOGY
- Caffeine protects against combined paraquat and maneb-induced dopaminergic neuron degeneration
- (2010) Anil Kachroo et al. EXPERIMENTAL NEUROLOGY
- Endogenous neuroprotection in chronic neurodegenerative disorders: with particular regard to the kynurenines
- (2010) Dénes Zádori et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- The relevance of iron in the pathogenesis of Parkinson’s disease
- (2010) Jeswinder Sian-Hülsmann et al. JOURNAL OF NEUROCHEMISTRY
- Rasagiline in Parkinson's Disease
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Urate as a Predictor of the Rate of Clinical Decline in Parkinson Disease
- (2009) Alberto Ascherio ARCHIVES OF NEUROLOGY
- Isradipine antagonizes hypobaric hypoxia induced CA1 damage and memory impairment: Complementary roles of L-type calcium channel and NMDA receptors
- (2009) Kalpana Barhwal et al. NEUROBIOLOGY OF DISEASE
- A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease
- (2009) C. Warren Olanow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Progress in neuroprotection in Parkinson’s disease
- (2008) A. H. V. Schapira EUROPEAN JOURNAL OF NEUROLOGY
- Disease-modifying drugs and Parkinson's disease
- (2007) Hervé Allain et al. PROGRESS IN NEUROBIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now